IRIS

RISITANO, ANTONIO MARIA

RISITANO, ANTONIO MARIA  

Dipartimento di Medicina clinica e Chirurgia  

Mostra records
Risultati 1 - 20 di 192 (tempo di esecuzione: 0.015 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Molecular Diagnostics in hematology 2.1 Contributo in volume (Capitolo o Saggio) 2009 Maciejewski, Jp; Selleri, C; Risitano, ANTONIO MARIA
Aplastic anemia: immunosuppression. Current challenges and future goals in immunosuppression for aplastic anemia. 1.1 Articolo in rivista 2009 Risitano, ANTONIO MARIA
Paroxysmal nocturnal hemoglobinuria 2.1 Contributo in volume (Capitolo o Saggio) 2012 Risitano, ANTONIO MARIA
Immune pathophysiology of aplstic anemia. 1.1 Articolo in rivista 2002 Jp, Maciejewski; Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Y. o. u. n. g.
Multi-center experience using total lymphoid irradiation and anti-thymocyte globulin as conditioning for allografting in hematological malignancies. 1.1 Articolo in rivista 2012 Messina, G; Giaccone, L; Festuccia, M; Irrera, G; Scortechini, I; Sorasio, R; Gigli, F; Passera, R; Cavattoni, I; Filippi, Ar; Schianca, Fc; Pini, M; Risitano, ANTONIO MARIA; Selleri, C; Levis, A; Mordini, N; Gallamini, A; Pastano, R; Casini, M; Aglietta, M; Montanari, M; Console, G; Boccadoro, M; Ricardi, U; Bruno, B.
In vivo dominant immune responses in aplastic anemia patients: molecular tracking of putatively pathogenic T cells by TCRb-CDR3 sequencing. 1.1 Articolo in rivista 2004 Risitano, ANTONIO MARIA; Maciejewski, Jp; Green, S; Plasilova, M; Zeng, W; Young, N. S.
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE 4.3 Poster 2013 Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Molecular Diagnostics in hematology. 2.1 Contributo in volume (Capitolo o Saggio) 2005 Maciejewski, Jp; Selleri, C; Risitano, ANTONIO MARIA
CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT 1.1 Articolo in rivista 2013 Marotta, Serena; Ricciardi, D.; Bertrando, A.; de Rosa, N.; Pagliuca, Simona; Basile, Santina; Cardano, F.; Pane, Fabrizio; DE ROSA, Gennaro; Piccoli, R.; Risitano, ANTONIO MARIA
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION 4.2 Abstract in Atti di convegno 2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY 1.5 Abstract in rivista 2011 Risitano, ANTONIO MARIA; Selleri, Carmine; Serio, Bianca; Marando, L.; Marotta, Serena; Raia, M.; De Palma, R.; DEL VECCHIO, Luigi; DE ROSA, Gennaro; Pane, Fabrizio
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA 1.5 Abstract in rivista 2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Significance of oligoclonal and polyclonal expansion within CD8 and CD4 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by VB CDR3 spectratyping and flow cytometry. 1.1 Articolo in rivista 2002 Risitano, ANTONIO MARIA; H., Kook; W., Zeng; G., Chen; Ns, Young; Jp, M. a. c. i. e. j. e. w. s. k. i.
Application of the molecular analsysis of the T –cell receptor repertoire in the study of immune-mediated hematologic disease. 1.1 Articolo in rivista 2002 Plasilova, M; Risitano, ANTONIO MARIA; Maciejewski, J. P.
Pathological clonal cytotoxic T cell responses - non random nature of the T cell receptor restriction in large granular lymphocytic leukemia. 1.1 Articolo in rivista 2005 Wlodarski, Mw; O’Keefe, C; Howe, Ec; Loughran J. r., Tp; Risitano, ANTONIO MARIA; Rodriguez, A; Warshawsky, I; Maciejewski, J. P.
A pilot study of the recombinant soluble human tumor necrosis factor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. 1.1 Articolo in rivista 2002 Jp, Maciejewski; Risitano, ANTONIO MARIA; L., Wisch; N., Geller; J., Barrett; Ns, Y. o. u. n. g.
Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. 1.1 Articolo in rivista 2008 Brodsky, Ra; Young, Ns; Antonioli, E; Risitano, ANTONIO MARIA; Schrezenmeier, H; Schubert, J; Valls, Ag; Coyle, L; de Castro, C; Fu, Cl; Maciejewski, Jp; Bessler, M; Kroon, Ha; Rother, Rp; Hillmen, P.
Preferential suppression of trisomy 8 versus normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodisplastic syndrome. 1.1 Articolo in rivista 2005 Sloand, Em; Mainwaring, L; Fuhrer, M; Ramkissoon, S; Risitano, ANTONIO MARIA; Keyvanafar, K; Lu, J; Basu, A; Barrett, Aj; Young, N. S.
Molecular analysis of T cell receptor clonotypes in LGL- A clonal model for polyclonal responses. 1.1 Articolo in rivista 2004 O’Keefe, C; Plasilova, M; Risitano, ANTONIO MARIA; Rodriguez, A; Hsi, E; Wlodarski, M; Young, Ns; Maciejewski, J. P.
Fas-mediated apoptosis is important in regulating cell replication and death in trysomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. 1.1 Articolo in rivista 2002 Em, Sloand; S., Kim; M., Fuhrer; Risitano, ANTONIO MARIA; R., Nakamura; J., Maciejewski; J., Barrett; Ns, Y. o. u. n. g.